StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
CIBC Downgrades Valeant Pharmaceuticals (VRX) to Sector Underperform
March 15, 2016 5:38 PM
CIBC downgraded Valeant Pharmaceuticals (NYSE: VRX) from Sector Perform to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades
Next Articles
Valeant (VRX) PT Cut to $53 at Jefferies
March 16, 2016 11:05 AM
Valeant Pharma (VRX) Adds to Gains on Rumor
March 16, 2016 10:12 AM
Drugmaker Valeant faces debt default risk; shares plunge 50 percent
March 15, 2016 6:20 AM
Valeant Pharma (VRX) Misses Q4 EPS by 11c; Cuts Q1, FY16 Outlook
March 15, 2016 6:03 AM
Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information
March 15, 2016 6:00 AM
